Anbio Biotechnology Balance Sheet (2023-2025) | NNNN

Balance Sheet Dec2023 Dec2024 Jun2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.01B0.01B5,348.49B0.01B
Short-term Investments (Quarter) 0.00B8,080.50B0.00B
Cash & Current Investments (Quarter) 0.01B0.01B13,428.99B0.01B
Receivables - Net (Quarter) 0.00B0.00B3,716.38B0.00B
Receivables - Other (Quarter) 948.00
Receivables (Quarter) 0.00B0.00B3,716.38B0.00B
Prepaid Assets (Quarter) 0.00B0.00B10,173.06B0.00B
Current Assets (Quarter) 0.02B0.02B27,680.59B0.03B
Non-Current Assets
Other Non-Current Assets (Quarter) 0.00B0.00B
Non-Current Assets (Quarter) 0.00B0.00B
Assets (Quarter) 0.02B0.02B27,680.59B0.03B
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.00B0.00B
Payables (Quarter) 0.00B0.00B
Accumulated Expenses (Quarter) 0.00B0.00B0.00B
Other Accumulated Expenses (Quarter) 0.00B0.00B0.00B
Total Current Liabilities (Quarter) 0.00B0.00B131.13B0.00B
Non-Current Liabilities
Total Liabilities (Quarter) 0.00B0.00B131.13B0.00B
Shareholder's Equity
Common Equity (Quarter) 0.01B0.02B27,549.47B0.03B
Shareholder's Equity (Quarter) 0.01B0.02B0.03B
Liabilities and Shareholders Equity (Quarter) 0.02B0.02B27,680.59B0.03B
Retained Earnings (Quarter) 0.01B0.02B20,971.45B0.02B